Quick medicine delivery platform Plazza has successfully raised $15 million in a Series A funding round co-led by Accel, Elevation Capital, and Nexus Venture Partners, with participation from existing investors All In Capital and Better Capital. According to reports from Business Standard, the fresh capital will be used to strengthen Plazza's technology platform, deepen its AI-driven inventory and assortment intelligence, build operational capabilities, and expand its pharmacy network into new geographies. The startup, founded in 2024 by Aman Priyadarshi, is positioning itself to compete in India's crowded pharmacy market through its unique delivery model that combines AI-powered inventory management with 15-30 minute delivery.
As reported by Business Standard, Plazza plans to launch 10 stores in the next eight weeks and aims to have 20 stores in Bengaluru by the end of this year. The company has been experimenting with a couple of stores in Bengaluru and now has the capital to increase its geographical footprint. In the coming year, Plazza expects to expand to other cities and is targeting over 3,000 stores in the next three to four years. The startup has grown GMV by about 27x between June 2024 and March 2025, with repeat customers now placing orders with an average basket size approximately 30% higher than first-time users, reflecting growing customer trust and increasing household adoption.
According to Business Standard, Plazza operates an omnichannel model with physical stores and online deliveries, prioritizing the latter. The company stocks over 40,000 stock-keeping units (SKUs) using AI-powered inventory intelligence to continuously learn local prescribing patterns. As reported, across its two Bengaluru stores, only around 50% of the top-selling medicines overlap, highlighting how significantly prescription behavior varies across micro-markets. The company's AI-driven approach focuses on a wider catchment area around its stores, along with quick deliveries, targeting the country's organized pharmacy retail space which has seen rapid consolidation dominated by giants such as Tata 1mg and Apollo 24/7.
As reported by Business Standard, Plazza differentiates itself from traditional pharmacies by stocking a larger inventory and offering quick deliveries of 15-30 minutes. While India's pharmaceutical retail market exceeds $30 billion, neighbourhood pharmacies typically stock only around 5,000 medicines out of a market comprising more than 100,000 SKUs, resulting in prescription fill rates of just 50-60%. Unlike traditional pharmacies that optimise for walk-in retail or epharmacies that prioritise inventory over speed, Plazza has built a new operating model combining AI-powered inventory intelligence, deep medicine availability, and prescription fill rates exceeding 95%. The company's AI-driven inventory planning adapts each store's assortment based on neighbourhood-level demand, solving one of India's most persistent healthcare access challenges through technology-enabled pharmacy retail.
